Archive

  • AXA IM Alts invests $25m in biopharmaceutical company Vedanta Biosciences

    26 April 2023

    As part of drive to fund affordable and innovative solutions to gastrointestinal diseases and malnutrition

Cookies on Insurance Asset Risk

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here